Author

C. A. Langford

Observed names: C A Langford, C Langford, C. A Langford, C. Langford, CA Langford, Langford, C, Langford, C., Langford, C. A.

Institution: Cleveland Clinic

Observed institutions: National Institutes of Health, Cleveland Clinic, National Institute of Allergy and Infectious Diseases

OpenAlex ID: A5113825642

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

2012 · J. C. Jennette, R. J. Falk, et al. · Arthritis & Rheumatism · 6,635

Rare diseases bullet 3: Wegener's granulomatosis

1999 · C. A Langford, G. S Hoffman · Thorax · 126

PDF

Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis

2011 · C A Langford · Clinical & Experimental Immunology · 55

Update on Wegener granulomatosis.

2005 · C. A Langford · Cleveland Clinic Journal of Medicine · 22

FRI0314 Different serum cytokine profiles reflect anti-neutrophil cytoplasmic antibodies (ANCA) specificity in patients with anca-associated vasculitis

2017 · A Berti, R Warner, et al. · Annals of the Rheumatic Diseases · 4

PDF

Retreatment with Rituximab in the RAVE Trial

2013 · E. Miloslavsky, U. Specks, et al. · La Presse Médicale · 4

THU0301 Safety following initiation of rituximab in granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA): interim analysis of the rituximab in anca-associated vasculitis registry (RAVER)

2017 · J Niles, N Allen, et al. · Annals of the Rheumatic Diseases · 3

PDF

OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial

2017 · ME Wechsler, P Akuthota, et al. · Annals of the Rheumatic Diseases · 1

PDF

Arteriovenous malformation of the brain mimicking primary central nervous system vasculitis

2008 · J. Hernández‐Rodríguez, E. S. Molloy, et al. · Scandinavian Journal of Rheumatology · 1

OP0061 A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis

2025 · M. Soowamber, M. Bond, et al. · Annals of the Rheumatic Diseases

Pos0082 Exploring the Genetic Basis of Clinical Heterogeneity in Giant Cell Arteritis

2025 · G. Borrego-Yaniz, V. Fuentes-Moreno, et al. · Annals of the Rheumatic Diseases

Ab0720 Development of Response Criteria for Gca: an Slr Informing an International Task Force

2023 · C. Sanchez-Alvarez, M. Bond, et al. · Annals of the Rheumatic Diseases

PDF

POS0244 ASSOCIATION OF PROTEINASE 3 GENE (PRTN3) Val119Ile POLYMORPHISM (SNP rs351111) WITH RISK OF RELAPSE AMONG HOMOZYGOUS PATIENTS WITH PR3 ANCA-ASSOCIATED VASCULITIS

2022 · M. Casal Moura, Z. Deng, et al. · Annals of the Rheumatic Diseases

PDF

Detection of circulating PR3-specific B cells in patients with active ANCA-associated vasculitis

2019 · Cornec, D., Berti, A, et al. · INRIA a CCSD electronic archive server

Characterization of preferential recognition of a chimeric recombinant proteinase 3 variant by anti-neutrophil cytoplasmic antibodies.

2018 · Thompson, G.A., Moura, M.C., et al. · PuSH - Publication Server of Helmholtz Zentrum München

OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial

2017 · Wechsler, ME, Akuthota, P, et al. · Apollo (University of Cambridge)

SAT0369 Weight Gain in Anca-Associated Vasculitis Is Independent of Glucocorticoid Dosing

2016 · Z. Wallace, E. Miloslavsky, et al. · Annals of the Rheumatic Diseases

Serum biomarkers during relapsing disease in eosinophilic granulomatosis with polyangiitis

2013 · C. Dejaco, P. Monach, et al. · La Presse Médicale

Evidence for the ANCA-associated vasculitis index of damage (AVID)

2007 · Seo, P., Merkel, P. A., et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)

Works count: 20

Citation count: 6,851

H-index: 4

I10-index: 4